Haşim Boyacı

764 total citations
45 papers, 486 citations indexed

About

Haşim Boyacı is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases. According to data from OpenAlex, Haşim Boyacı has authored 45 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 23 papers in Physiology and 5 papers in Infectious Diseases. Recurrent topics in Haşim Boyacı's work include Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers), Asthma and respiratory diseases (11 papers) and Respiratory Support and Mechanisms (7 papers). Haşim Boyacı is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers), Asthma and respiratory diseases (11 papers) and Respiratory Support and Mechanisms (7 papers). Haşim Boyacı collaborates with scholars based in Türkiye, United States and Kuwait. Haşim Boyacı's co-authors include İlknur Başyiğit, Füsun Yıldız, Ahmet Ilgazlı, Sevgiye Kaçar Özkara, Serap Argun Barış, Can Duman, Nilay Etiler, Hale Maral Kır, Cengiz Erçín and Dilek Ural and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and Molecular and Cellular Biochemistry.

In The Last Decade

Haşim Boyacı

38 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haşim Boyacı Türkiye 10 203 189 106 87 67 45 486
İlknur Başyiğit Türkiye 10 224 1.1× 193 1.0× 112 1.1× 84 1.0× 69 1.0× 39 521
Füsun Yıldız Türkiye 14 389 1.9× 361 1.9× 128 1.2× 78 0.9× 80 1.2× 69 735
Göksel Kıter Türkiye 11 185 0.9× 190 1.0× 68 0.6× 23 0.3× 42 0.6× 34 407
Andréanne Côté Canada 13 273 1.3× 299 1.6× 44 0.4× 67 0.8× 41 0.6× 48 609
K.P. Hui Singapore 11 308 1.5× 376 2.0× 41 0.4× 40 0.5× 50 0.7× 16 613
Teija Dunder Finland 14 293 1.4× 230 1.2× 132 1.2× 17 0.2× 125 1.9× 28 572
Fernando Sergio Leitão Filho Brazil 14 254 1.3× 178 0.9× 62 0.6× 28 0.3× 65 1.0× 40 566
Agnieszka Strzelak Poland 6 136 0.7× 154 0.8× 29 0.3× 57 0.7× 56 0.8× 10 515
Aleksander Adamiec Poland 5 140 0.7× 119 0.6× 28 0.3× 55 0.6× 57 0.9× 8 465
SF Paul Man Canada 11 416 2.0× 239 1.3× 39 0.4× 19 0.2× 60 0.9× 15 606

Countries citing papers authored by Haşim Boyacı

Since Specialization
Citations

This map shows the geographic impact of Haşim Boyacı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haşim Boyacı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haşim Boyacı more than expected).

Fields of papers citing papers by Haşim Boyacı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haşim Boyacı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haşim Boyacı. The network helps show where Haşim Boyacı may publish in the future.

Co-authorship network of co-authors of Haşim Boyacı

This figure shows the co-authorship network connecting the top 25 collaborators of Haşim Boyacı. A scholar is included among the top collaborators of Haşim Boyacı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haşim Boyacı. Haşim Boyacı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Boyacı, Haşim, et al.. (2024). The predictive effects of adiponectin and irisin hormones on diagnosis and clinical involvement of Sarcoidosis. BMC Pulmonary Medicine. 24(1). 623–623. 1 indexed citations
4.
Barış, Serap Argun, et al.. (2022). Charlson Comorbidity Index in Predicting Poor Clinical Outcomes and Mortality in Patients with COVID-19. PubMed. 23(2). 145–153. 20 indexed citations
5.
Sağlam, Melda, et al.. (2021). Occupational Competence and Activities of Daily Living Performance in Bronchial Asthma. Canadian Journal of Occupational Therapy. 88(3). 214–219. 4 indexed citations
6.
Barış, Serap Argun, et al.. (2021). Reduced Rate of Hospital Admission for Exacerbation of COPD and Asthma During COVID-19 Pandemic. PubMed. 22(6). 510–511. 1 indexed citations
7.
Ilgazlı, Ahmet, et al.. (2017). Latent tuberculosis infection in healthcare workers at a tertiary care center. Biomedical Research-tokyo. 28(2). 657–662. 4 indexed citations
8.
Barış, Serap Argun, et al.. (2016). The effect of positive airway pressure therapy on neurocognitive functions, depression and anxiety in obesity hypoventilation syndrome. Multidisciplinary Respiratory Medicine. 11(1). 35–35. 9 indexed citations
9.
Boyacı, Haşim, İlknur Başyiğit, & Serap Argun Barış. (2013). Positron emission tomography/computed tomography in cases with tuberculosis mimicking lung cancer. The Brazilian Journal of Infectious Diseases. 17(2). 267–269. 8 indexed citations
10.
Yıldız, Füsun, Serap Argun Barış, İlknur Başyiğit, & Haşim Boyacı. (2011). Kocaeli İl Merkezindeki Okullarda Görev Yapmakta Olan Öğretmenlerde Sigara İçme Alışkanlıklarının Değerlendirilmesi. 12(1). 9–12.
11.
Boyacı, Haşim, et al.. (2006). Fetustaki sigara dumanı maruziyetinin kord kanı kotinin düzeyi ile değerlendirilmesi. Kocaeli Üniversitesi - AVESİS. 7(2). 115–119. 1 indexed citations
12.
Boyacı, Haşim, et al.. (2006). Environmental tobacco smoke exposure in school children: parent report and urine cotinine measures. Pediatrics International. 48(4). 382–389. 60 indexed citations
13.
Başyiğit, İlknur, Göksel Kahraman, Ahmet Ilgazlı, Füsun Yıldız, & Haşim Boyacı. (2005). The Effects of Levofloxacin on ECG Parameters and Late Potentials. American Journal of Therapeutics. 12(5). 407–410. 8 indexed citations
14.
Yıldız, Füsun, et al.. (2005). Different bronchodilator combinations have similar effects on health status in COPD. Pulmonary Pharmacology & Therapeutics. 19(2). 101–106. 8 indexed citations
15.
Başyiğit, İlknur, et al.. (2005). Addition of inhaled corticosteroid on combined bronchodilator therapy in patients with COPD. Pulmonary Pharmacology & Therapeutics. 18(6). 422–426. 8 indexed citations
16.
Başyiğit, İlknur, Füsun Yıldız, Sevgiye Kaçar Özkara, Haşim Boyacı, & Ahmet Ilgazlı. (2004). Inhaled corticosteroid effects both eosinophilic and non‐eosinophilic inflammation in asthmatic patients. Mediators of Inflammation. 13(4). 285–291. 26 indexed citations
17.
Yıldız, Füsun, et al.. (2004). Does addition of inhaled steroid to combined bronchodilator therapy affect health status in patients with COPD?. Respirology. 9(3). 352–355. 9 indexed citations
18.
Ağaçdiken, Ayşen, İlknur Başyiğit, Meltem Özden Yüce, et al.. (2004). The effects of antioxidants on exercise‐induced lipid peroxidation in patients with COPD. Respirology. 9(1). 38–42. 32 indexed citations
19.
Ilgazlı, Ahmet, Haşim Boyacı, İlknur Başyiğit, & Füsun Yıldız. (2004). Extrapulmonary tuberculosis: clinical and epidemiologic spectrum of 636 cases. Archives of Medical Research. 35(5). 435–441. 83 indexed citations
20.
Boyacı, Haşim, et al.. (2003). Kocaeli Üniversitesi Öğrencilerinin Sigara İçme Alişkanliklarinin Değerlendirilmesi. 14(3). 169–175. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026